LAB · Standard BioTools Inc
United States · RS rating 17 · As of 2026-11-03
| Price | 0.61 USD |
|---|---|
| 1-day change | +0.1% |
| RS rating (overall / 1M / 3M / 12M) | 17 / 22 / 29 / 22 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 24 / 9 / 40 |
| Industry group (rank) | Medical-Systems/Equip (86) |
| EPS growth Q/Q | +155.6% |
| Sales growth Q/Q | +21.7% |
| Distance from 52-week high | +63.6% |
| Market cap (USD) | $348.7M |